These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 33506309)

  • 1. Value of integrated PET-IVIM MRI in predicting lymphovascular space invasion in cervical cancer without lymphatic metastasis.
    Xu C; Yu Y; Li X; Sun H
    Eur J Nucl Med Mol Imaging; 2021 Aug; 48(9):2990-3000. PubMed ID: 33506309
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combinative evaluation of primary tumor and lymph nodes to predict pelvic lymphatic metastasis in cervical cancer: an integrated PET-IVIM MRI study.
    Xu C; Li X; Shi Y; Wang B; Sun H
    Cancer Imaging; 2020 Mar; 20(1):21. PubMed ID: 32143736
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Value of integrated PET-IVIM MR in assessing metastases in hypermetabolic pelvic lymph nodes in cervical cancer: a multi-parameter study.
    Xu C; Du S; Zhang S; Wang B; Dong C; Sun H
    Eur Radiol; 2020 May; 30(5):2483-2492. PubMed ID: 32040728
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship between
    Du S; Sun H; Gao S; Xin J; Lu Z; Chen Z; Pan S; Guo Q
    Clin Radiol; 2019 Mar; 74(3):178-186. PubMed ID: 30545566
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combinative evaluation of primary tumor and lymph nodes in predicting pelvic lymphatic metastasis in early-stage cervical cancer: A multiparametric PET-CT study.
    Li K; Sun H; Guo Q
    Eur J Radiol; 2019 Apr; 113():153-157. PubMed ID: 30927941
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prediction of treatment response in patients with locally advanced cervical cancer using midtreatment PET/MRI during concurrent chemoradiotherapy.
    Vojtíšek R; Baxa J; Kovářová P; Almortaza A; Hošek P; Sukovská E; Tupý R; Ferda J; Fínek J
    Strahlenther Onkol; 2021 Jun; 197(6):494-504. PubMed ID: 33492444
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PET/MRI in Cervical Cancer: Associations Between Imaging Biomarkers and Tumor Stage, Disease Progression, and Overall Survival.
    Shih IL; Yen RF; Chen CA; Cheng WF; Chen BB; Chang YH; Cheng MF; Shih TT
    J Magn Reson Imaging; 2021 Jan; 53(1):305-318. PubMed ID: 32798280
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiparametric PET/MR (PET and MR-IVIM) for the evaluation of early treatment response and prediction of tumor recurrence in patients with locally advanced cervical cancer.
    Gao S; Du S; Lu Z; Xin J; Gao S; Sun H
    Eur Radiol; 2020 Feb; 30(2):1191-1201. PubMed ID: 31493211
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synergic role of preoperative 18F-fluorodeoxyglucose PET and MRI parameters in predicting histopathological features of endometrial cancer.
    Mapelli P; Ironi G; Bergamini A; Mangili G; Rancoita PM; Taccagni GL; Venturini E; Petrone M; Nisi V; Fallanca F; De Marzi P; Colarieti A; Candotti G; Bocciolone L; Candiani M; Gianolli L; Picchio M; De Cobelli F
    Nucl Med Commun; 2020 Oct; 41(10):1073-1080. PubMed ID: 32925826
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor Size at Magnetic Resonance Imaging Association With Lymph Node Metastasis and Lymphovascular Space Invasion in Resectable Cervical Cancer: A Multicenter Evaluation of Surgical Specimens.
    Chen XL; Chen GW; Xu GH; Ren J; Li ZL; Pu H; Li H
    Int J Gynecol Cancer; 2018 Oct; 28(8):1545-1552. PubMed ID: 30044321
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Application of Simultaneous
    Huang Z; Li X; Wang Z; Meng N; Fu F; Han H; Li D; Bai Y; Wei W; Fang T; Feng P; Yuan J; Yang Y; Wang M
    J Magn Reson Imaging; 2022 Jul; 56(1):63-74. PubMed ID: 34888990
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Roles of DWI and T2-weighted MRI volumetry in the evaluation of lymph node metastasis and lymphovascular invasion of stage IB-IIA cervical cancer.
    Wang Y; Chen X; Pu H; Yuan Y; Li S; Chen G; Liu Y; Li H
    Clin Radiol; 2022 Mar; 77(3):224-230. PubMed ID: 35000761
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prediction of lymphovascular space invasion using a combination of tenascin-C, cox-2, and PET/CT radiomics in patients with early-stage cervical squamous cell carcinoma.
    Li X; Xu C; Yu Y; Guo Y; Sun H
    BMC Cancer; 2021 Jul; 21(1):866. PubMed ID: 34320931
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prediction of cervical metastasis and survival in cN0 oral cavity cancer using tumour
    Bae MR; Roh JL; Kim JS; Choi SH; Nam SY; Kim SY
    J Cancer Res Clin Oncol; 2020 Dec; 146(12):3341-3348. PubMed ID: 32642973
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sensitivity and specificity of amide proton transfer-weighted imaging for assessing programmed death-ligand 1 status in non-small cell lung cancer: a comparative study with intravoxel incoherent motion and
    Meng N; Fu F; Sun J; Feng P; Luo Y; Wu Y; Li X; Yuan J; Yang Y; Liu H; Wang Z; Wang M
    Quant Imaging Med Surg; 2022 Sep; 12(9):4474-4487. PubMed ID: 36060584
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic value of metabolic tumor volume and total lesion glycolysis from ¹⁸F-FDG PET/CT in lymph node metastases and risk stratification of endometrial carcinoma.
    Liu DD; Li J; Li X; Xie L; Qin L; Peng F; Cheng MH
    J Gynecol Oncol; 2019 Nov; 30(6):e89. PubMed ID: 31576685
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined pre-treatment MRI and 18F-FDG PET/CT parameters as prognostic biomarkers in patients with cervical cancer.
    Miccò M; Vargas HA; Burger IA; Kollmeier MA; Goldman DA; Park KJ; Abu-Rustum NR; Hricak H; Sala E
    Eur J Radiol; 2014 Jul; 83(7):1169-1176. PubMed ID: 24767630
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The feasibility of
    Liu S; Xia L; Yang Z; Ge H; Wang C; Pan H; Song S; Zhou Z
    Cancer Imaging; 2020 Sep; 20(1):63. PubMed ID: 32912310
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hybrid PET/MRI in Staging Endometrial Cancer: Diagnostic and Predictive Value in a Prospective Cohort.
    Ironi G; Mapelli P; Bergamini A; Fallanca F; Candotti G; Gnasso C; Taccagni GL; Sant'Angelo M; Scifo P; Bezzi C; Bettinardi V; Rancoita PMV; Mangili G; Bocciolone L; Candiani M; Gianolli L; De Cobelli F; Picchio M
    Clin Nucl Med; 2022 Mar; 47(3):e221-e229. PubMed ID: 35067539
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic utility of metabolic parameters on FDG PET/CT for lymph node metastasis in patients with cN2 non-small cell lung cancer.
    Nakanishi K; Nakamura S; Sugiyama T; Kadomatsu Y; Ueno H; Goto M; Ozeki N; Fukui T; Iwano S; Chen-Yoshikawa TF
    BMC Cancer; 2021 Sep; 21(1):983. PubMed ID: 34474680
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.